Market Place
Sourcing Support
Onco360 Named National Pharmacy Partner for Itovebi™
11 Nov 2024 //
GLOBENEWSWIRE
Genentech axes Nykode cancer vaccine deal
09 Nov 2024 //
FIERCE BIOTECH
Genentech to Share Long-term Data at ASH 2024 Hematology
05 Nov 2024 //
BUSINESSWIRE
Genentech’s Itovebi Shows Landmark Phase 3 Results in Breast Cancer
30 Oct 2024 //
BUSINESSWIRE
Roche MAGE-A4 trial withdrawn after strategic review
19 Oct 2024 //
FIERCE BIOTECH
Genentech’s Vabysmo Improves Vision In DME Underrepresented Groups
18 Oct 2024 //
BUSINESSWIRE
Jazz`s almost-withdrawn lung cancer drug shows life
16 Oct 2024 //
PR NEWSWIRE
Roche`s Evrysdi Shows Positive Results In Children With SMA
14 Oct 2024 //
GLOBENEWSWIRE
Genentech`s Itovebi (Inavolisib) Receives Approval in US
10 Oct 2024 //
FDA
Mindpeak Secures $15.3M For AI-Based Digital Pathology
30 Sep 2024 //
BUSINESSWIRE
Regor, Genentech to Acquire Regor`s Portfolio for CDK of Breast Cancer
30 Sep 2024 //
PR NEWSWIRE
Positive Ph 3 Results for Gazyva Show Superior to Std Therapy alone
26 Sep 2024 //
BUSSINESSWIRE
Genentech`s Biologic Actemra(Tocilizumab) Receives Suppl Approval in US
19 Sep 2024 //
FDA
Xofluza Phase III Results Reduce Influenza Virus Transmission
19 Sep 2024 //
BUSINESSWIRE
FDA Approves Ocrevus Zunovo For Multiple Sclerosis
13 Sep 2024 //
BUSINESSWIRE
Genentech`s Biologic Zunovo (Hyaluronidase) Receives in US
13 Sep 2024 //
FDA
Genentech`s Biologic Ocrevus (Ocrelizumab) Receives Approval in US
13 Sep 2024 //
FDA
FDA Approves Genentech`s Subcutaneous Cancer Immunotherapy
12 Sep 2024 //
BUSINESSWIRE
Genentech`s cancer restructure was made `for scientific reasons`: exec
10 Sep 2024 //
FIERCE BIOTECH
Genentech to Lay Off 93 in San Francisco
28 Aug 2024 //
BIOSPACE
Genentech to shut down cancer immunology department amid broader R&D rethink
19 Aug 2024 //
FIERCE BIOTECH
Genentech, ADA Plot Program To Improve Diabetes-Related Eye Health
07 Aug 2024 //
FIERCE PHARMA
Relay loses interest in SHP2 inhibitor after Genentech abandons collab
07 Aug 2024 //
FIERCE BIOTECH
Onco360® Has Been Selected as a National Specialty Pharmacy for crovalimab-akkz
05 Aug 2024 //
GLOBENEWSWIRE
Genentech`s Site Alliance Boosts Diverse Patient Enrollment
05 Aug 2024 //
FIERCE BIOTECH
Genentech takes to TikTok to push biomarker testing message
02 Aug 2024 //
FIERCE PHARMA
Genentech takes SMA song ‘Spaces’ to the White House for Disability Pride Month
30 Jul 2024 //
FIERCE PHARMA
Genentech sinks SHP2 pact, leaving Relay to race thinning field
17 Jul 2024 //
FIERCE BIOTECH
Roche to reintroduce eye implant med Susvimo 2 years after recall
08 Jul 2024 //
FIERCE PHARMA
Porton And Genentech Publish Breakthrough In Crystallization Research
05 Jul 2024 //
PRESS RELEASE
Genentech Updates On Phase II/III SKYSCRAPER-06 Study In Lung Cancer
04 Jul 2024 //
BUSINESSWIRE
Inovalon and Genentech Study Reveals Racial Disparities in Liver Cancer Care
25 Jun 2024 //
GLOBENEWSWIRE
Genentech Inc Biologic Ocrelizumab Receives Approval in US
21 Jun 2024 //
FDA
Genentech Inc Biologic Crovalimab-Akkz Receives Approval in US
20 Jun 2024 //
FDA
Genentech`s Trastuzumab; Hyaluronidase-Oysk Receives Suppl Approval in US
18 Jun 2024 //
FDA
Genentech Biologic Trastuzumab Receives Suppl Approval in US
18 Jun 2024 //
FDA
Genentech`s Columvi Extends Survival In R R DLBCL
14 Jun 2024 //
BUSINESSWIRE
DiMe, Big Pharmas collab on framework for digital endpoints
12 Jun 2024 //
FIERCE BIOTECH
Italy starts probe into Lucentis biosimilar delay allegation
08 Jun 2024 //
PHARMAPHORUM
Novartis, Roche unit and others face Italy antitrust probe over eye drug
07 Jun 2024 //
REUTERS
Enforcement Report - Week of June 5, 2024
05 Jun 2024 //
FDA
FDA Priority Review: Genentech`s Inavolisib For PIK3CA+ Breast Cancer
29 May 2024 //
BUSINESSWIRE
FDA Grants Genentech`s Inavolisib Breakthrough For PIK3CA Breast Cancer
21 May 2024 //
BUSINESSWIRE
Genentech Reports Positive Phase Ib Obesity Results For GLP-1/GIP Agonist CT-388
16 May 2024 //
BUSINESSWIRE
Adaptimmune’s debt financing deal; Tenaya to cut workers
15 May 2024 //
ENDPTS
Genentech animated short spotlights docs` trust in Vabysmo
13 May 2024 //
FIERCE PHARMA
Alecensa approved as 1st adjuvant for ALK+ early lung cancer
18 Apr 2024 //
BUSINESSWIRE
Genentech’s Columvi Meets Primary Endpoint Ref. Diffuse Large B-Cell Lymphoma
15 Apr 2024 //
PRESS RELEASE
Genentech`s Columvi Meets DLBCL STARGLO Survival Endpoint
15 Apr 2024 //
BUSINESSWIRE
Genentech plans to cut 3% of workforce across several units, company says
10 Apr 2024 //
ENDPTS
Seagen’s former commercial chief joins the board at healthcare agency
22 Mar 2024 //
ENDPTS
Genentech`s Biologic Xolair (omalizumab) Receives Approval in the U.S.
16 Feb 2024 //
FDA
Genentech`s Biologic Lucentis (ranibizumab) Receives Approval in the U.S.
15 Feb 2024 //
FDA
Genentech`s Biologic Pulmozyme (dornase alfa) Receives Approval in the U.S.
09 Feb 2024 //
FDA
Genentech is Broadway bound with latest campaign
07 Feb 2024 //
ENDPTS
GenEdit Announces Multiyear Collaboration and License Agreement with Genentech
23 Jan 2024 //
BUSINESSWIRE
Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
23 Jan 2024 //
FIERCE BIOTECH
Roche’s Genentech returns Alzheimer’s assets to AC Immune
22 Jan 2024 //
FIERCE BIOTECH
Genentech`s Biologic Ocrevus (ocrelizumab) Receives Approval in the U.S.
19 Jan 2024 //
FDA
